Prediagnosis biomarkers of insulin-like growth factor-1, insulin, and interleukin-6 dysregulation and multiple myeloma risk in the Multiple Myeloma Cohort Consortium

Novel therapies in MM: from the aspect of preclinical studies

(2011) Teru Hideshima et al.   INTERNATIONAL JOURNAL OF HEMATOLOGY

Obesity is associated with an increased risk of monoclonal gammopathy of undetermined significance among black and white women

(2010) O. Landgren et al.   BLOOD

Growth factors in multiple myeloma: a comprehensive analysis of their expression in tumor cells and bone marrow environment using Affymetrix microarrays

(2010) Karène Mahtouk et al.   BMC CANCER

Monoclonal gammopathy of undetermined significance (MGUS) and smoldering (asymptomatic) multiple myeloma: IMWG consensus perspectives risk factors for progression and guidelines for monitoring and management

(2010) R A Kyle et al.   LEUKEMIA

Insulin is a potent myeloma cell growth factor through insulin/IGF-1 hybrid receptor activation

(2010) A C Sprynski et al.   LEUKEMIA

Advances in the Diagnosis, Classification, Risk Stratification, and Management of Monoclonal Gammopathy of Undetermined Significance: Implications for Recategorizing Disease Entities in the Presence of Evolving Scientific Evidence

(2010) S. Vincent Rajkumar et al.   MAYO CLINIC PROCEEDINGS

Plasma carotenoids and risk of acute myocardial infarction in the Singapore Chinese Health Study

(2010) W.-P. Koh et al.   NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES

Monoclonal gammopathy of undetermined significance (MGUS) consistently precedes multiple myeloma: a prospective study

(2009) O. Landgren et al.   BLOOD

Increased risk of monoclonal gammopathy in first-degree relatives of patients with multiple myeloma or monoclonal gammopathy of undetermined significance

(2009) C. M. Vachon et al.   BLOOD

Blood Pressure Differences by Ethnic Group Among United States Children and Adolescents

(2009) Bernard Rosner et al.   HYPERTENSION

Reduction of serum IGF-I levels in patients affected with Monoclonal Gammopathies of undetermined significance or Multiple Myeloma. Comparison with bFGF, VEGF and K-ras gene mutation

(2009) Claudia Greco et al.   JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

IGF-dependent and IGF-independent actions of IGF-binding protein-1 and -2: implications for metabolic homeostasis

(2009) Stephen B. Wheatcroft et al.   TRENDS IN ENDOCRINOLOGY AND METABOLISM

Determination of Blood Pressure Percentiles in Normal-Weight Children: Some Methodological Issues

(2008) B. Rosner et al.   AMERICAN JOURNAL OF EPIDEMIOLOGY